Labeler
Novugen Pharma (USA) LLC NDC Codes
Novugen Pharma (USA) LLC lists 27 finished drug products in the FDA NDC Directory under NDC labeler code 82293.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lenalidomide, everolimus, Sacubitril and Valsartan, Sunitinib Malate, Midodrine Hydrochloride, Mycophenolic Acid, Abiraterone Acetate, Macitentan, pazopanib
- Active ingredients
- Lenalidomide, Everolimus, Sacubitril, Valsartan, Sunitinib malate, Midodrine hydrochloride, Mycophenolate sodium, Abiraterone acetate, Macitentan, Pazopanib hydrochloride
- NDC labeler codes
- 82293
- Strengths
- Sacubitril 97 mg/1; Valsartan 103 mg/1; Macitentan 10 mg/1; Everolimus 2.5 mg/1; Everolimus 5 mg/1; Everolimus 7.5 mg/1; Everolimus 10 mg/1; Lenalidomide 2.5 mg/1; Lenalidomide 5 mg/1; Lenalidomide 10 mg/1; Lenalidomide 15 mg/1; Lenalidomide 20 mg/1; Lenalidomide 25 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Mycophenolate sodium 180 mg/1; Mycophenolate sodium 360 mg/1; Sunitinib malate 12.5 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Tablet, Tablet, Delayed release
- Routes
- Oral
- Drug classes (FDA established)
- Kinase Inhibitor, Thalidomide Analog, mTOR Inhibitor Immunosuppressant, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, alpha-Adrenergic Agonist, Antimetabolite Immunosuppressant, Cytochrome P450 17A1 Inhibitor, Endothelin Receptor Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 45
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | 82293-041 | 82293-0041-1082293-0041-2082293-0041-30 | — |
| everolimus | Everolimus 2.5 mg/1 | TabletOral | 82293-030 | 82293-0030-1082293-0030-2182293-0030-31 | — |
| everolimus | Everolimus 5 mg/1 | TabletOral | 82293-031 | 82293-0031-1082293-0031-2182293-0031-31 | — |
| everolimus | Everolimus 7.5 mg/1 | TabletOral | 82293-032 | 82293-0032-1082293-0032-2182293-0032-31 | — |
| everolimus | Everolimus 10 mg/1 | TabletOral | 82293-033 | 82293-0033-1082293-0033-2182293-0033-31 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 82293-006 | 82293-0006-10 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 82293-007 | 82293-0007-10 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 82293-008 | 82293-0008-10 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 82293-009 | 82293-0009-10 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 82293-010 | 82293-0010-10 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 82293-011 | 82293-0011-10 | — |
| Sacubitril and Valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | 82293-027 | 82293-0027-1082293-0027-2082293-0027-30 | — |
| Sacubitril and Valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | 82293-028 | 82293-0028-1082293-0028-2082293-0028-30 | — |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | 82293-029 | 82293-0029-1082293-0029-2082293-0029-30 | — |
| Sacubitril and Valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | 82293-040 | 82293-0040-1082293-0040-2082293-0040-30 | — |
| Mycophenolic Acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | 82293-012 | 82293-0012-10 | — |
| Mycophenolic Acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | 82293-013 | 82293-0013-10 | — |
| Sunitinib Malate | Sunitinib malate 12.5 mg/1 | CapsuleOral | 82293-014 | 82293-0014-10 | — |
| Sunitinib Malate | Sunitinib malate 25 mg/1 | CapsuleOral | 82293-015 | 82293-0015-10 | — |
| Sunitinib Malate | Sunitinib malate 37.5 mg/1 | CapsuleOral | 82293-016 | 82293-0016-10 | — |
| Sunitinib Malate | Sunitinib malate 50 mg/1 | CapsuleOral | 82293-017 | 82293-0017-10 | — |
| pazopanibpazopanib hydrochloride | Pazopanib hydrochloride 200 mg/1 | Tablet, Film coatedOral | 82293-022 | 82293-0022-10 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 2.5 mg/1 | TabletOral | 82293-003 | 82293-0003-10 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 5 mg/1 | TabletOral | 82293-004 | 82293-0004-10 | — |
| Midodrine Hydrochloride | Midodrine hydrochloride 10 mg/1 | TabletOral | 82293-005 | 82293-0005-10 | — |
| Abiraterone Acetate | Abiraterone acetate 250 mg/1 | Tablet, Film coatedOral | 82293-001 | 82293-0001-10 | — |
| Abiraterone Acetate | Abiraterone acetate 500 mg/1 | Tablet, Film coatedOral | 82293-002 | 82293-0002-10 | — |
Novugen Pharma (USA) LLC: common questions
- What is Novugen Pharma (USA) LLC's NDC labeler code?
- 82293. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Novugen Pharma (USA) LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.